object
optim
clinic
laboratori
diagnosi
suspect
case
likelihood
ratio
igm
igg
antibodi
method
reinterpret
data
articl
diagnost
valu
combin
detect
serum
novel
coronaviru
igm
igg
antibodi
novel
coronavirusin
infect
posit
likelihood
ratio
igm
igg
antibodi
diagnosi
nucleic
acid
posit
patient
calcul
posterior
probabl
igm
igg
antibodi
tandem
detect
diagnos
final
calcul
result
posit
likelihood
ratio
singl
igm
igg
antibodi
respect
posterior
probabl
respect
howev
posterior
probabl
two
antibodi
tandem
detect
give
clinician
quantit
confid
diagnosi
suspect
case
accord
result
studi
combin
advantag
disadvantag
nucleic
acid
detect
antibodi
detect
clinic
pathway
clinician
diagnos
found
conclus
suspect
case
igm
igg
antibodi
test
firstli
done
time
antibodi
test
posit
confirm
nucleic
acid
detect
one
time
perform
extrem
case
highthroughput
viral
genom
sequenc
perform
confirm
case
admit
peopl
hospit
affliat
wuhan
univers
suspect
case
consid
follow
epidemiolog
histori
clinic
manifest
epidemiolog
histori
histori
travel
resid
wuhan
surround
area
commun
case
report
within
day
prior
onset
diseas
contact
novel
coronaviru
infect
peopl
posit
result
nucleic
acid
test
within
day
prior
onset
diseas
contact
patient
fever
respiratori
symptom
wuhan
surround
area
commun
confirm
case
report
within
day
onset
diseas
cluster
case
case
fever
andor
respiratori
symptom
small
area
famili
offic
school
etc
within
week
viru
specif
igg
detect
reach
titrat
least
increas
convalesc
compar
acut
phase
posit
likelihood
ratio
lr
igm
igg
suspect
case
nucleic
acid
posit
patient
calcul
mainli
reinterpret
data
articl
diagnost
valu
combin
detect
serum
novel
coronaviru
igm
igg
antibodi
novel
coronaviru
infect
accord
relev
data
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
nucleic
acid
detect
antibodi
detect
advantag
disadvantag
first
aspect
specimen
sampl
commonli
use
specimen
nucleic
acid
detect
sputum
nasopharynx
swab
variou
lung
lavag
fluid
sampl
great
infect
risk
medic
personnel
also
potenti
infect
risk
laboratori
personnel
nucleic
acid
detect
howev
type
antibodi
test
specimen
blood
rel
easi
obtain
infect
risk
medic
personnel
rel
low
secondli
accord
qualiti
detect
result
nucleic
acid
detect
restrict
qualiti
sampl
materi
extract
qualiti
nucleic
acid
seriou
undetect
phenomenon
differ
sampl
type
differ
detect
rate
sucha
bronchoalveolar
lavag
fluid
specimen
show
highest
posit
rate
sputum
nasal
swab
fibrobronchoscop
brush
biopsi
pharyng
swab
fece
blood
continu
nucleic
acid
detect
sever
time
suspect
patient
necessari
effect
avoid
fals
neg
result
antibodi
detect
except
immunocompromis
patient
produc
antibodi
effect
antibodi
present
infect
person
antibodi
detect
mainli
limit
sensit
relat
perform
kit
addit
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
obtain
diagnost
valu
combin
detect
serum
novel
coronaviru
igm
igg
antibodi
novel
coronaviru
infect
diagnost
perform
index
tandem
test
analyz
paper
howev
studi
solv
problem
calcul
posterior
probabl
lr
prove
posterior
probabl
two
antibodi
tandem
test
much
higher
singl
antibodi
detect
posterior
probabl
singl
antibodi
detect
much
differ
show
singl
antibodi
test
significantli
increas
confid
clinician
clear
diagnosi
confirm
case
suspect
case
howev
two
antibodi
tandem
test
obvious
improv
confid
make
clinician
confid
diagnosi
increas
help
clinician
optim
diagnosi
process
quantif
method
studi
clinic
pathway
clinician
diagnos
suspect
case
igm
igg
antibodi
test
firstli
done
time
antibodi
test
posit
confirm
nucleic
acid
detect
one
time
perform
extrem
case
highthroughput
viral
genom
sequenc
perform
short
use
posit
likelihood
ratio
calcul
posterior
probabl
could
better
reflect
tandem
detect
two
antibodi
compar
convent
diagnost
perform
indic
practic
work
help
clinician
optim
diagnosi
process
addit
studi
aim
secondari
excav
publish
literatur
data
futur
origin
data
use
sampl
size
expand
verifi
conclus
